1291.3000 40.70 (3.25%)
NSE Sep 09, 2025 15:31 PM
Volume: 1.6M
 

ICICI Securities Limited
US remains a key driver, contributing ~37% to revenues as of FY21. DRL has a strong pending pipeline comprising 92 ANDAs (47 Para IV filings, 23 FTFs) and three NDAs under 505 (b) (2) route. We expect US sales to grow...
Dr. Reddy's Laboratories Ltd.'s price crossed above 30Day SMA today
More from Dr. Reddy's Laboratories Ltd.
Recommended